Personalized CRISPR therapies could soon reach thousands — here’s how

A new approach to trialing CRISPR therapies for rare genetic diseases could make their production economically viable, potentially enabling treatment for thousands. The study, published in Nature, highlights advancements in personalized medicine for genetic disorders.